It is important to note that the negative regulatory effect of protein tyrosine phosphatase 1B (PTP1B) in the insulin signaling pathway makes it a promising therapeutic target for Type II diabetes mellitus treatment [51]. This evidence concerns the gene INS and type 2 diabetes mellitus.